AVTX logo

AVTX

Avalo Therapeutics, Inc.NASDAQHealthcare
$17.76+6.35%ClosedMarket Cap: $200.6M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-25HC Wainwright & Co.Buy
2026-03-24BTIGBuy
2026-01-15HC Wainwright & Co.Buy
2025-09-29BTIGBuy
2025-09-17HC Wainwright & Co.Buy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-3.99$1.0M6
Sun Dec 31$-3.95$13.9K6
Mon Dec 31$-3.91$11.1M4
Tue Dec 31$-2.18$119.9M2